Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07671599 · ClinicalTrials.gov registry record
Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- 150
- Enrollment target
NCT07671599 is a clinical trial that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants.
The verdict
NCT07671599 has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
Interventions
- DEVICE Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-09 |
| Est. Completion | 2028-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07671599
The ClinicalTrials.gov registry entry for NCT07671599 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.
NCT07671599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07671599 about?
NCT07671599 is a clinical study titled "Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)". This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose tr...
What is the current status of trial NCT07671599?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2026-09. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07671599?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT07671599?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.